scPharmaceuticals Inc. (SCPH) financial statements (2021 and earlier)

Company profile

Business Address 2400 DISTRICT AVENUE
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1057389
Cash and cash equivalents727389
Short-term investments33  
Receivables 00
Prepaid expense332
Other current assets000
Total current assets:1087692
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment000
Restricted cash and investments000
Other undisclosed noncurrent assets002
Total noncurrent assets:122
TOTAL ASSETS:1097794
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities654
Accounts payable211
Accrued liabilities543
Debt203
Other undisclosed current liabilities0 0
Total current liabilities:957
Noncurrent Liabilities
Long-term debt and lease obligation17207
Long-term debt, excluding current maturities17197
Operating lease, liability01
Liabilities, other than long-term debt010
Other liabilities000
Derivative instruments and hedges, liabilities 1 
Other undisclosed noncurrent liabilities  1
Total noncurrent liabilities:18218
Total liabilities:272615
Stockholders' equity
Stockholders' equity attributable to parent825179
Common stock000
Additional paid in capital244181175
Accumulated other comprehensive income0  
Accumulated deficit(162)(129)(96)
Total stockholders' equity:825179
TOTAL LIABILITIES AND EQUITY:1097794

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit:00 
Operating expenses(30)(33)(30)
Other undisclosed operating loss(0)(0) 
Operating loss:(30)(33)(30)
Nonoperating income022
Investment income, nonoperating022
Interest and debt expense(3)(2)(1)
Net loss available to common stockholders, diluted:(32)(33)(29)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(32)(33)(29)
Comprehensive loss:(32)(33)(29)
Other undisclosed comprehensive income, net of tax, attributable to parent0  
Comprehensive loss, net of tax, attributable to parent:(32)(33)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: